PREZISTA is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Janssen Products Lp. The primary component is Darunavir Ethanolate.
| Product ID | 59676-565_04a6e608-8107-11eb-8ef7-26defb2ca371 |
| NDC | 59676-565 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PREZISTA |
| Generic Name | Darunavir |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-12-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202895 |
| Labeler Name | Janssen Products LP |
| Substance Name | DARUNAVIR ETHANOLATE |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2011-12-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202895 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-12-16 |
| Ingredient | Strength |
|---|---|
| DARUNAVIR ETHANOLATE | 100 mg/mL |
| SPL SET ID: | 814301f9-c990-46a5-b481-2879a521a16f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-1327 | PREZISTA | darunavir |
| 50090-1491 | PREZISTA | darunavir |
| 53808-0672 | PREZISTA | darunavir ethanolate |
| 53808-0773 | PREZISTA | darunavir ethanolate |
| 59676-562 | PREZISTA | darunavir |
| 59676-563 | PREZISTA | darunavir |
| 59676-564 | PREZISTA | darunavir |
| 59676-565 | PREZISTA | darunavir |
| 70518-0689 | PREZISTA | PREZISTA |
| 70518-1483 | PREZISTA | PREZISTA |
| 59676-566 | PREZISTA | PREZISTA |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PREZISTA 78762650 3236346 Live/Registered |
JANSSEN SCIENCES IRELAND UNLIMITED COMPANY 2005-11-29 |
![]() PREZISTA 77239629 not registered Dead/Abandoned |
Tibotec Pharmaceuticals Ltd. 2007-07-26 |